Skip to main content
Log in

HPV vaccination more cost effective in younger than older patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 US dollars

  2. Advisory Committee on Immunization Practices

Reference

  • Chesson HW, et al. Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model. Vaccine : 26 Oct 2020. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.10.019

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HPV vaccination more cost effective in younger than older patients. PharmacoEcon Outcomes News 866, 17 (2020). https://doi.org/10.1007/s40274-020-7277-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7277-4

Navigation